CITE2 Polyclonal Antibody

The protein encoded by this gene inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.

The CITE2 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CITE2 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of the human CITE2 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards the target protein, making it an ideal tool for a wide range of applications in research and diagnostics.

The CITE2 Polyclonal Antibody has been extensively validated for its performance in various immunoassays, including Western blotting, immunohistochemistry, and ELISA. It has been shown to detect CITE2 protein in a variety of human tissues and cell lines, with minimal cross-reactivity to other proteins. The antibody is supplied as a purified IgG fraction, which has been affinity-purified from rabbit serum using protein A chromatography. This ensures high purity and consistency of the antibody, which is essential for reproducible results.

The CITE2 Polyclonal Antibody is a valuable tool for researchers studying the role of CITE2 protein in various biological processes, including cell proliferation, differentiation, and apoptosis. It can also be used for the development of diagnostic assays for diseases associated with CITE2 protein dysregulation. Overall, the CITE2 Polyclonal Antibody is a reliable and high-quality reagent that can enhance the accuracy and sensitivity of your research or diagnostic assays.